Kala Pharmaceuticals

Watertown,  MA 
United States
http://www.kalarx.com
  • Booth: 701


Kala Pharmaceuticals welcomes you.

Kala is a biopharmaceutical company focused on innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® Drug Delivery Technology to two ocular therapies, EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25% and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1%.  The Company also has a pipeline of proprietary NCE development programs.

Brands: AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery.


 Products

  • EYSUVIS®
    EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25% - First and only prescription therapy specifically for the short-term management of the signs and symptoms of dry eye disease....

  • EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25% - First and only prescription therapy specifically for the short-term management of the signs and symptoms of dry eye disease.
  • INVELTYS®
    INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% - First and only BID corticosteroid indicated for the treatment of post-operative ocular inflammation and pain....

  • INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% - First and only BID corticosteroid indicated for the treatment of post-operative ocular inflammation and pain.

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".


For Technical Support with this webpage, please contact support.